Oral Solid Dosage Pharmaceutical Formulation Market Size, Trends And Forecast Report 2024-2033

"The new report published by The Business Research Company, titled Oral Solid Dosage Pharmaceutical Formulation Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the oral solid dosage pharmaceutical formulation market size has grown strongly in recent years. It will grow from $583.07 billion in 2023 to $618.34 billion in 2024 at a compound annual growth rate (CAGR) of 6.0%. The oral solid dosage pharmaceutical formulation market size is expected to see strong growth in the next few years. It will grow to $792.37 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15626&type=smp

Chronic Disease Prevalence Drive Growth In The Oral Solid Dosage Pharmaceutical Formulation Market
The increasing prevalence of chronic diseases is expected to propel the growth of the oral solid dosage pharmaceutical formulation market going forward. Chronic diseases refer to long-term health conditions that persist for an extended period, typically lasting for three months or more. Chronic diseases is rising due to factors such as aging populations, sedentary lifestyles, poor dietary habits, environmental factors, and improved detection and diagnosis methods. Oral solid dosage pharmaceutical formulations are integral to chronic disease management and support long-term treatment adherence, as they are convenient, stable, and precise dosing. For instance, in July 2021, according to the IDF Diabetes Atlas Tenth Edition 2021 report published by the International Diabetes Federation, a Belgium-based national diabetes association organization, the global number of people aged 20-78 years having diabetes is expected to reach 643 million by 2030, and 783 million by 2045 from 537 million in 2021. Therefore, the increasing prevalence of chronic diseases drives the growth of the oral solid dosage pharmaceutical formulation market.

Liquid-Filled Capsules Transforming Oral Solid Dosage Pharmaceutical Formulation Market
Major companies operating in the oral solid dosage pharmaceutical formulation market are developing innovative products, such as liquid-filled capsules, to enhance drug delivery, improve bioavailability, and offer more convenient dosing options for patients. Liquid-filled capsules are oral dosage forms consisting of a gelatin shell filled with a liquid or semi-solid formulation containing active pharmaceutical ingredients (APIs) and excipients. For instance, in July 2023, Zeon Lifesciences Ltd., an India-based pharmaceutical company, launched liquid-filled capsules, offering a cutting-edge delivery system with enhanced bioavailability and absorption rates. These capsules feature an innovative delivery system that enhances bioavailability and absorption rates, ensuring optimal levels of active ingredients for maximum efficacy and immediate results. Zeon's liquid-filled capsules provide precise and consistent dosages, improving patient compliance and control over medication administration. These capsules utilize advanced technologies to enhance bioavailability, improve patient outcomes, and protect the medication's integrity. Zeon's liquid-filled capsules offer a convenient, effective, and reliable alternative to traditional dosage forms, setting a new standard for patient care and compliance in the pharmaceutical industry.

The oral solid dosage pharmaceutical formulation market covered in this report is segmented -

1) By Dosage Form: Tablets, Capsules, Powders And Granules, Lozenges And Pastilles,
2) By Mechanism: Controlled-Release, Immediate-Release, Delayed-Release
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies, Hypermarkets Or Supermarkets
4) By End-User: Large-Size Companies, Medium And Small-Size Companies, Other End-Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @ https://www.thebusinessresearchcompany.com/Discount?id=15626&type=discount

Major companies operating in the oral solid dosage pharmaceutical formulation market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca Plc., Novartis AG, Hoffman-La-Roche Ltd., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim GmbH, Gilead Sciences, Amgen Inc., Teva Pharmaceuticals, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Biogen Inc., Lonza Group, Catalent Inc., Ashland Inc., Piramal Pharma Solutions, Jubilant Pharmova, CordenPharma International

Contents of the report:
1. Executive Summary
2. Oral Solid Dosage Pharmaceutical Formulation Market Report Structure
3. Oral Solid Dosage Pharmaceutical Formulation Market Trends And Strategies
4. Oral Solid Dosage Pharmaceutical Formulation Market - Macro Economic Scenario
5. Oral Solid Dosage Pharmaceutical Formulation Market Size And Growth
…..
27. Oral Solid Dosage Pharmaceutical Formulation Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/oral-solid-dosage-pharmaceutical-formulation-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.